In psychopharmacology of depression, we observe two ways of research. One group is focused on catecholamines action. Second one fixes attention on neuronal morphogenesis and synaptic plasticity. The intimate connection of astrocytes, neurons and synaptic endings determines glial participation in neural homeostasis. Consequently this situation enlarges the role of astrocytes in the CNS synaptic plasticity. Brain Derived Neurotrophic factor and its receptor TrkB suppose to coordinate both of the above mentioning signaling pathways in depression disturbances. In our experiment, we have exploited striatal tissue because in our opinion this structure is misjudged in pathophysiology of depression alas; Several hypothesis proposed striatum as important in future intention activity structure. RT-PCR analysis was used to determine D 1 , BDNF and TrkB mRNA expression in cultured striatal astroglial cells. Administration of three representative antidepressants (ADs) like amitriptyline, moclobemide and sertraline to astroglial culture medium increase the D 1 , BDNF/TrkB mRNA expression. Our previous study showed that the stimulation of cAMP to CREB pathway after D 1 receptors excitation constituted a common response to ADs. The present results signify that D 1 , BDNF/TrkB link which is next neural track (after cAMP/PKA) involved in the CNS adaptation to external conditions altered by chronic ADs treatment. Moreover, the striatum tissue appears to be important formation which takes an active part in antidepressant action thus essential in depression disorder etiology.
Introduction
Depression is not only life-threating illness (thoughts and suicides attempts) but also serious social problem (loss of interest in daily activities) and economic difficulty (one of the main causes of long-term work absenteeism). Despite dynamic progress in pharmacology and neuropsychology and synthesis of new generations of antidepressant drugs, pathogenesis of depression, is still unknown.
Up until now, there has been also not much success in univocal establishing of the type of neurochemical transmission responsible for the mechanism of multidirectional action of this structurally diverse group of drugs. Dysfunction of the serotonergic and noradrenergic system and long term brain adaptation process as an important aspect of ADs action seem to be the best documented so far as catecholaminergic supposition of depression.
Right now, major of experiments focused on neuronal morphogenesis, neurodegenerative processes and neuronplastic changes in the brain as helpful approaches to clarify etiology of depression and ADs action [1] .
Evidences from animal studies support thesis that brain derived neurotrophic factor, member of the neurotrophin family, is a very important protein which regulates neuron cell life activity through membrane receptors TrkB [1, 2] . Next, it is well known that BDNF/ TrkB-stimulated signaling is necessary for morphogenesis and neuronal plasticity involved in the pathophysiology of depression [2] [3] [4] [5] .
Previous experiments conducted in our laboratory have confirmed at the molecular level the contribution of dopaminergic neurotransmission by D 1 receptors→ade-nylyl-cyclase→cAMP→CREB signaling to the mechanism of action of antidepressant drugs [6] [7] [8] .
The aim of this study was to establish type of changes in BDNF/TrkB mRNA expression in glial cultures after chronically administered antidepressants acting via different mechanisms [5, 9, 10] .
To be able to directly compare the results we chose the same representatives of ADs as there tested for previous study like: amitriptyline, moclobemide and sertraline.
Materials and Methods

Cell Culture
Striatal astroglial cells were isolated from 1-day-old Wistar rats and cultured according to the method of Hertz [11] . Astrocytes were grown on 35 × 10 mm Falcon dishes covered with poly-D-lysine. The culture medium initially contained 20% FBS was replaced by 10% FBS after 4 days. The culture was changed twice a week at about 14 days. The cells were further cultured for next 2 weeks. In addition cultures were treated with amitriptyline or moclobemide, or sertraline at 10 mM concentration with every 2 days medium-mix change. Immunocytochemical analysis of cultures was shown 90% -95% GFAP-positive cells.
Ten following experiments for three different ADs respectively were done.
RNA Isolation
Total RNA was isolated from 10 cell dishes (35 × 10 mm) by Chomczynski [12] extraction method with the TRIzol reagent. Isolated and purified RNA was dissolved in nuclease-free water (Promega) quantified by determining absorbance at 240 and 260 nm, preserving proportion 1OD 260 = 40 mg/ml RNA and stored at −70˚C before use. The OD 260 /OD 280 ratio of the isolated samples ranged 1.8 -2.0, indicating that the material was not contaminated by DNA. Purity testing confirmed proper choice of procedure and reagents for isolation. Starters for RT-PCR were designed using Primer 3 software, from genBank details. Only TrkB starters nucleotide sequence is taken from an A. Bahi, paper [13] .
Compositions of starter nucleotides are presented in the RT-PCR products were separated by electrophoresis on 2% LMP agarose for separation of short nucleotides (Promega) labeled with ethidium bromide (1 mg/ml). Aliquots of RT-PCR product (10 ml) were collected and 3 ml of loading solution for electrophoresis (40% sucrose, 0.25% bromophenol blue) were added to each sample and loaded in slots of the gel. Electrophoresis was developed in TAE 1x buffer (pH8.0), and run parallel to DNA marker (pUC19/MspI) Figure 1. 
Statistical Analysis of Results
Images of the obtained electrophoretic separations were stored using BioProfile E software (France) for data archiving. Densitometric measurements of RT-PCR products after electrophoretic separation were performed using a semiquantitive method vs. data obtained for constitutive gene using LabWorks software (UVP, UK). as shown in Figure 1 . All data are represented as the means ± SEM of the mean relative optical density (ROD), after background subtractions, which were subjected to statistical analysis using one-way ANOVA followed by Dunnett's test for specific comparisons [14] . Significance was established at a level of p < 0.05 and p < 0.01. (Figure 2) analysis present increase of D 1 and BDNF/TrkB mRNA expression in cultured striatal astroglial cells exposed to long term administration of different (in pharmacologic proceedings) ADs to culture medium (amitriptyline, moclobemide, sertraline).
Results
RT-PCR
We have shown previously [6] that chronic use of ADs increases expression of dopamine D 1 family receptors in both striatal and nucleus accumbens neurons. The present study was designed to investigate chronic effects of ADs on cultured astrocytes dopamine receptors. Our study showed next time that used antidepressants significantly increase dopamine D 1 receptor gene expression.
Discussion
Results of the present work indicate that chronic ADs treatment increases BDNF/TrkB mRNA expression in striatal astroglial cells. They are in good according with our reports that cAMP→CREB→BDNF pathway stimulation is a common response to ADs with different initial mechanism of action [15, 16] . In our opinion BDNF and its receptor TrkB control and coordinate synaptic changes in depression disturbances and brain reaction to external ADs action stimulus as well. Another important aspect of BDNF is its involvement in the cross-talk between different signaling mechanism: biological and molecular. In addition we next time observe high expression of dopamine D 1 type receptor. In light of previews studies conducted in our laboratory, this observation provides next support to the hypothesis implicating DA in the mechanism of ADs [6, 8, 17] . 
Conclusion
Our result presents molecule evidence for functional role of D 1 , BDNF/TrkB link action in long term CNS adaptation. These findings signify that alteration in neurotrophins' family may play key role in pathophysiology of mood disorder. We suppose in addition that our results may be useful to select narrow spectrum of gene markers important in depression illness to potential phamacogenetic studies of the future new antidepressants.
